205 related articles for article (PubMed ID: 12065196)
1. Effects on serotonin in rat hypothalamus of D-fenfluramine, aminorex, phentermine and fluoxetine.
Tao R; Fray A; Aspley S; Brammer R; Heal D; Auerbach S
Eur J Pharmacol; 2002 Jun; 445(1-2):69-81. PubMed ID: 12065196
[TBL] [Abstract][Full Text] [Related]
2. The effect of the anorectic agent, d-fenfluramine, and its primary metabolite, d-norfenfluramine, on intact human platelet serotonin uptake and efflux.
Johnson GJ; Leis LA; Dunlop PC; Weir EK
J Thromb Haemost; 2003 Dec; 1(12):2663-8. PubMed ID: 14675103
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia.
Raiteri M; Bonanno G; Vallebuona F
J Pharmacol Exp Ther; 1995 May; 273(2):643-9. PubMed ID: 7752066
[TBL] [Abstract][Full Text] [Related]
4. Combined phentermine/fenfluramine administration enhances depletion of serotonin from central terminal fields.
Lew R; Weisenberg B; Vosmer G; Seiden LS
Synapse; 1997 May; 26(1):36-45. PubMed ID: 9097403
[TBL] [Abstract][Full Text] [Related]
5. Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: therapeutic implications.
Baumann MH; Ayestas MA; Dersch CM; Brockington A; Rice KC; Rothman RB
Synapse; 2000 May; 36(2):102-13. PubMed ID: 10767057
[TBL] [Abstract][Full Text] [Related]
6. Aminorex, fenfluramine, and chlorphentermine are serotonin transporter substrates. Implications for primary pulmonary hypertension.
Rothman RB; Ayestas MA; Dersch CM; Baumann MH
Circulation; 1999 Aug; 100(8):869-75. PubMed ID: 10458725
[TBL] [Abstract][Full Text] [Related]
7. Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
Wellman PJ; Jones SL; Miller DK
Pharmacol Biochem Behav; 2003 Apr; 75(1):103-14. PubMed ID: 12759118
[TBL] [Abstract][Full Text] [Related]
8. Anorectic efficacy of the fenfluramine/phentermine combination in rats: additivity or synergy?
Roth JD; Rowland NE
Eur J Pharmacol; 1999 Jun; 373(2-3):127-34. PubMed ID: 10414430
[TBL] [Abstract][Full Text] [Related]
9. d-Fenfluramine and d-norfenfluramine hypophagias do not require increased hypothalamic 5-hydroxytryptamine release.
Oluyomi AO; Gibson EL; Barnfield AM; Curzon G
Eur J Pharmacol; 1994 Oct; 264(1):111-5. PubMed ID: 7828639
[TBL] [Abstract][Full Text] [Related]
10. Effects of fenfluramine and phentermine (fen-phen) on dopamine and serotonin release in rat striatum: in vivo microdialysis study in conscious animals.
Balcioglu A; Wurtman RJ
Brain Res; 1998 Nov; 813(1):67-72. PubMed ID: 9824670
[TBL] [Abstract][Full Text] [Related]
11. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor.
Gundlah C; Martin KF; Heal DJ; Auerbach SB
J Pharmacol Exp Ther; 1997 Nov; 283(2):581-91. PubMed ID: 9353373
[TBL] [Abstract][Full Text] [Related]
12. Differences in hypothalamic serotonin between estrous phases and gender: an in vivo microdialysis study.
Gundlah C; Simon LD; Auerbach SB
Brain Res; 1998 Feb; 785(1):91-6. PubMed ID: 9526054
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of fenfluramine-induced hyperthermia in rats by some, but not all, selective inhibitors of 5-hydroxytryptamine uptake.
Sugrue MF
Br J Pharmacol; 1984 Apr; 81(4):651-7. PubMed ID: 6722394
[TBL] [Abstract][Full Text] [Related]
14. Effect of chronic D-fenfluramine administration on rat hypothalamic serotonin levels and release.
Schaechter JD; Wurtman RJ
Life Sci; 1989; 44(4):265-71. PubMed ID: 2464733
[TBL] [Abstract][Full Text] [Related]
15. Local perfusion of corticosterone in the rat medial hypothalamus potentiates D-fenfluramine-induced elevations of extracellular 5-HT concentrations.
Feng N; Telefont M; Kelly KJ; Orchinik M; Forster GL; Renner KJ; Lowry CA
Horm Behav; 2009 Jun; 56(1):149-57. PubMed ID: 19371745
[TBL] [Abstract][Full Text] [Related]
16. Fluoxetine increases the anorectic and long-term dopamine-depleting effects of phentermine.
Callahan BT; Yuan J; Ricaurte GA
Synapse; 2000 Dec; 38(4):471-6. PubMed ID: 11044894
[TBL] [Abstract][Full Text] [Related]
17. Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
Garattini S; Bizzi A; Caccia S; Mennini T
Int J Obes Relat Metab Disord; 1992 Dec; 16 Suppl 3():S43-50. PubMed ID: 1338321
[TBL] [Abstract][Full Text] [Related]
18. Extracellular serotonin and 5-hydroxyindoleacetic acid in hypothalamus of the unanesthetized rat measured by in vivo dialysis coupled to high-performance liquid chromatography with electrochemical detection: dialysate serotonin reflects neuronal release.
Auerbach SB; Minzenberg MJ; Wilkinson LO
Brain Res; 1989 Oct; 499(2):281-90. PubMed ID: 2478259
[TBL] [Abstract][Full Text] [Related]
19. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
Currie PJ; Coscina DV; Fletcher PJ
Brain Res; 1998 Jul; 800(1):62-8. PubMed ID: 9685586
[TBL] [Abstract][Full Text] [Related]
20. Effects of fluoxetine or D-fenfluramine on serotonin release from, and levels in, rat frontal cortex.
Sarkissian CF; Wurtman RJ; Morse AN; Gleason R
Brain Res; 1990 Oct; 529(1-2):294-301. PubMed ID: 1704283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
